KR102349061B9 - 생착능이 증가된 줄기세포의 제조 방법 - Google Patents
생착능이 증가된 줄기세포의 제조 방법Info
- Publication number
- KR102349061B9 KR102349061B9 KR1020190030032A KR20190030032A KR102349061B9 KR 102349061 B9 KR102349061 B9 KR 102349061B9 KR 1020190030032 A KR1020190030032 A KR 1020190030032A KR 20190030032 A KR20190030032 A KR 20190030032A KR 102349061 B9 KR102349061 B9 KR 102349061B9
- Authority
- KR
- South Korea
- Prior art keywords
- stem cells
- preparing stem
- improved engraftment
- engraftment
- improved
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190030032A KR102349061B1 (ko) | 2019-03-15 | 2019-03-15 | 생착능이 증가된 줄기세포의 제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190030032A KR102349061B1 (ko) | 2019-03-15 | 2019-03-15 | 생착능이 증가된 줄기세포의 제조 방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20200110025A KR20200110025A (ko) | 2020-09-23 |
KR102349061B1 KR102349061B1 (ko) | 2022-01-10 |
KR102349061B9 true KR102349061B9 (ko) | 2022-09-30 |
Family
ID=72708680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190030032A KR102349061B1 (ko) | 2019-03-15 | 2019-03-15 | 생착능이 증가된 줄기세포의 제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102349061B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4212616A1 (en) * | 2020-09-14 | 2023-07-19 | Generoath Co., Ltd. | Method for preparing stem cells having improved engraftment capability |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101869268B1 (ko) * | 2011-05-30 | 2018-06-20 | 서울대학교산학협력단 | 줄기세포 재생 또는 증식능 향상용 세포 침투성 융합 단백질 |
-
2019
- 2019-03-15 KR KR1020190030032A patent/KR102349061B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20200110025A (ko) | 2020-09-23 |
KR102349061B1 (ko) | 2022-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276600A (en) | Methods for producing T cells | |
IL276597A (en) | A method for producing a low antigenic cell | |
HK1212148A2 (en) | A method for the isolation and cultivation of mesenchymal stem cells from umbilical cords, and a method for the differentiation of the umbilical cord-derived mesenchymal stem cells into various mesenchymal tissues | |
GB2588311B8 (en) | Method for preparing biochar | |
GB201707143D0 (en) | Method for producing cells | |
IL279172A (en) | Methods for the production of hematopoietic stem cells | |
IL283331A (en) | Method for the preparation of n-phenylpyrazole-1-carboxamides | |
EP3578641A4 (en) | PROCESS FOR PREPARING DENTAL PULP STEM CELLS FROM CELLS DERIVED FROM DENTAL PULP TISSUE | |
IL281751A (en) | Methods for inducing differentiation in mesenchymal stem cells | |
IL277878A (en) | Preparations and methods for stem cell transplantation | |
IL277467A (en) | A method for producing natural killer cells | |
EP3587559A4 (en) | MANUFACTURING METHOD FOR ARTIFICIAL PLURIPOTENT STEM CELLS | |
EP4053267A4 (en) | METHOD FOR PRODUCING T CELLS | |
EP4055009C0 (en) | METHOD OF MANUFACTURING DEXMEDETOMIDINE | |
GB201708554D0 (en) | A method for the generation of induced pluirpotent stem cells | |
SG11201809222UA (en) | Method for producing activated stem cells | |
SG11202109760YA (en) | Electropolishing method | |
KR102349061B9 (ko) | 생착능이 증가된 줄기세포의 제조 방법 | |
GB201909178D0 (en) | Methods for preparing compounds | |
KR102275418B9 (ko) | 리튬 비스플루오로술포닐이미드의 제조방법 | |
EP3597734A4 (en) | PROCESS FOR THE PRODUCTION OF AUXILIARY T LYMPHOCYTES FROM PLURIPOTENT STEM CELLS | |
GB201805308D0 (en) | Manufacturing methods for prosthetics | |
EP3508569A4 (en) | METHOD FOR OBTAINING MICROGLY FROM PLURIPOTENT STEM CELLS | |
GB2595411B (en) | Method for making tea cubes using micronized tea and tea cubes made by the method | |
IL282108A (en) | A method for preparing epiconazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |